A US government advisory panel has recommended emergency approval for the Pfizer-BioNTech coronavirus vaccine, underlining that the shot's potential benefits outweigh its risks. India, meanwhile, has said no compromise has been made on scientific and regulatory norms related to the Covid-19 vaccine.